Skip to main content

Table 1 Clinicopathologic features, treatment modalities, and follow-up data of SCTAT cases

From: Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study

No. Age Previous treatment Side of tumor: size Treatment Recurreces Treatment for subsequent recurrence Follow-up
Onset Admission Surgery Chemo Month Outcome
1 18 26 aRSO Right:- aTAH + LSO + RTR + LN biopsy PVB*3 2 - 146 DOD
2 31 34 aLSO Left:7 cm aTAH + RSO + omentum + LND + RTR+ RPL 5-Fu*1,N-formylsarcolysin *5,TSPA*2 3 Chemo: PVB*4; aRTR + RPL + RT 179 PR
3 15 15 No Right:30 cm aRSO nitrosourea 0 - 84 CR
4 8 8 No Left:9 cm aLSO + biopsy of right ovary - 0 - 48 CR
5 31 31 No right:13 cm;left:microscopic aRSO and biopsy of left ovary - 0 - 24 CR
6 21 29 aRSO Right:24 cm aTAH + LSO + RTR  + omentum PVB*2 3 aRTR;RT 143 PR
7 18 20 aLSO; RTR + RPL + RT + Chemo Left:20 cm aRTR + RPL + LND PEB*3 2 - 26 CR
8 39 39 No Right:5 cm bRSO and biopsy of left ovary - 0 - 55 CR
9 6 6 aBiopsy of ovary Left:8 cm aLSO - 0 - 63 CR
10 39 39 No Right:12 cm aTAH + BSO + LND + omentum PEB*3 0 - 107 CR
11 29 30 aLSO Left:6 cm aRTR + RPL + LND PEB*3 1 - 21 CR
12 34 34 No Right:12+cm bCystectomy - 3 aRSO + RTR + omentum + appendix; RTRa + chemo; RTRa 51 PR
13 5 5 No Left:8 cm bBiopsy of ovary; bLSO - 0 - 20 CR
  1. Note: Chemo, chemotherapy; RSO, right salpingo-oophorectomy; TAH, total abdominal hysterectomy; LSO, left salpingo-oophorectomy; RTR, recurrent tumor resection; LN, lymph nodes; RPL, retroperitoneal lymphadenectomy; DOD, died of disease; 5-Fu, 5-fluorouracil; TSPA, Thiotepa; PVB, cisplatin + vinblastine + bleomycin; RT, radiotherapy; PR, partial remission; CR, complete remission; PEB, cisplatin + etoposide + bleomycin; BSO, bilateral salpingo-oophorectomy; LND, lymph node dissection; alaparotomy; blaparoscopy.